February 18, 2026 04:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message | India’s wholesale inflation rises to 1.81% in January as manufacturing prices surge | 'India at forefront of AI revolution': PM Modi welcomes world leaders to Delhi summit | Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers
India-Canada
Image Credit: Covishield Twitter handle

India commits to ship Covishield vaccines to Canada within a month

| @indiablooms | Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" Poonawalla said in a tweet, using the brand name under which Serum produces the shot developed by Oxford University and AstraZeneca Plc.

Earlier, Canada's Prime Minister Justin Trudeau had also been assured by India's Prime Minister Narendra Modi during their discussion on Monday, that India would do its best to supply COVID-19 vaccines sought by Canada.

"Minister Anand continues to make every effort to ensure that vaccines are delivered to Canada as early as possible from a diverse range of suppliers. We will announce details of any agreement once it is finalized," said James Fitz-Morris in an email.

Approval of two separate applications for a vaccine developed by AstraZeneca and Oxford University researchers, including a joint pitch from SII, a private enterprise in Pune in western India, is being reviewed by Health Canada.

Canada has a deal with AstraZeneca for 20 million doses.

(Reporting by Asha Bajaj)
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.